Erectile dysfunction and benign prostatic hyperplasia: Two frequent pathologies of the aging male

被引：0
|
作者：
Ferretti, L. [1 ]
Robert, G. [1 ]
De La Taille, A. [2 ]
机构：
[1] CHU Bordeaux, Serv Urol, F-33000 Bordeaux, France
[2] CHU Henri Mondor, Serv Urol, F-94000 Creteil, France
来源：
PROGRES EN UROLOGIE | 2012年 / 22卷 / 03期
关键词：
Erectile dysfonction; Benign Prostatic; Hyperplasia; Low urinary tract symptoms; URINARY-TRACT SYMPTOMS; SEXUAL DYSFUNCTION; MEN; ASSOCIATION; INHIBITION;
D O I：
10.1016/j.fpurol.2012.05.001
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
Introduction. - Benign prostatic hyperplasia (BPH) end erectile dysfunction (ED) are frequently observed in the aging male. Materials and methods. - A systematic review of the literature was performed on Pubmed including the keywords "erectile dysfonction", "benign prostatic hyperplasia" and/or "low urinary tract symptoms". Results. - Eighteen manuscripts were selected, including 10 retrospective clinical studies, four of basic science, three of pharmacology and a review article. A significant relationship was found in most of the studies, and physiopathological hypothesis as atherosclerosis and autonomic hyperactivity were enlighten. Conclusion. - A statistical independent relationship exists between BPH and ED. The use of PDE-5i could be interesting regarding the common pathological process involved. (C) 2012 Published by Elsevier Masson SAS.
引用
收藏
页码：F78 / F82
页数：5
相关论文
共 50 条
  • [21] Relationship between Dietary Patterns with Benign Prostatic Hyperplasia and Erectile Dysfunction: A Collaborative Review
    Russo, Giorgio Ivan
    Broggi, Giuseppe
    Cocci, Andrea
    Capogrosso, Paolo
    Falcone, Marco
    Sokolakis, Ioannis
    Gul, Murat
    Caltabiano, Rosario
    Di Mauro, Marina
    NUTRIENTS, 2021, 13 (11)
  • [22] A review of the use of tadalafil in the treatment of benign prostatic hyperplasia in men with and without erectile dysfunction
    Hatzimouratidis, Konstantinos
    THERAPEUTIC ADVANCES IN UROLOGY, 2014, 6 (04) : 135 - 147
  • [23] Benign prostatic hyperplasia and sexual dysfunction
    Jefferson, K
    Persad, R
    LANCET, 2003, 361 (9368): : 1562 - 1562
  • [24] Pharmacologic Therapy in Men's Health Hypogonadism, Erectile Dysfunction, and Benign Prostatic Hyperplasia
    Berkseth, Kathryn E.
    Thirumalai, Arthi
    Amory, John K.
    MEDICAL CLINICS OF NORTH AMERICA, 2016, 100 (04) : 791 - +
  • [25] Aging-Related Mitochondrial Dysfunction Is Associated With Fibrosis in Benign Prostatic Hyperplasia
    Adrian, Alexis E.
    Liu, Teresa T.
    Pascal, Laura E.
    Bauer, Scott R.
    Defranco, Donald B.
    Ricke, William A.
    JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES, 2024, 79 (06):
  • [26] Erectile dysfunction in the aging male
    Lizette J. Smith
    Current Sexual Health Reports, 2005, 2 (1) : 13 - 16
  • [27] Erectile impotence after surgery of benign prostatic hyperplasia
    Guy, L
    Savareux, L
    Soares, P
    Boisgard, S
    Boiteux, JP
    JOURNAL OF UROLOGY, 2004, 171 (04): : 355 - 355
  • [28] Impact of Benign Prostatic Hyperplasia Surgery on Erectile Function
    Martinez-Jabaloyas, Jose M.
    Villamon-Fort, Rafael
    Gil-Salom, Manuel
    UROLOGIA INTERNATIONALIS, 2010, 84 (04) : 407 - 412
  • [29] Lower urinary tract symptoms related to benign prostatic hyperplasia and erectile dysfunction: A systematic review
    Peyronnet, Benoit
    Seisen, Thomas
    Phe, Veronique
    Misrai, Vincent
    de la Taille, Alexandre
    Roupret, Morgan
    PRESSE MEDICALE, 2017, 46 (02): : 145 - 153
  • [30] Epidemiology and risk factors of lower urinary tract symptoms/benign prostatic hyperplasia and erectile dysfunction
    Calogero, Aldo E.
    Burgio, Giovanni
    Condorelli, Rosita A.
    Cannarella, Rossella
    La Vignera, Sandro
    AGING MALE, 2019, 22 (01): : 12 - 19
12345